Phathom Pharmaceuticals Announces 2024 Annual Meeting of Stockholders

TL;DR

<b>Phathom Pharmaceuticals will host its 2024 Annual Meeting of Stockholders virtually on May 23, 2024, encouraging all shareholders to vote.</b>

AI Summary

Phathom Pharmaceuticals, Inc. (PHAT) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. Phathom Pharmaceuticals, Inc. will hold its annual meeting of stockholders on May 23, 2024, at 10:00 a.m. Eastern Time. The meeting will be conducted solely online via a live webcast for ease of stockholder access and participation. Stockholders can vote and submit questions online during the meeting at www.virtualshareholdermeeting.com/PHAT2024. The proxy statement details matters to be considered by stockholders at the annual meeting. The company urges stockholders to vote as soon as possible via proxy card, internet, or telephone.

Why It Matters

For investors and stakeholders tracking Phathom Pharmaceuticals, Inc., this filing contains several important signals. The virtual format aims to increase accessibility and participation for stockholders, allowing them to vote and ask questions remotely. The proxy statement provides essential information for stockholders to make informed decisions on matters presented at the annual meeting.

Risk Assessment

Risk Level: low — Phathom Pharmaceuticals, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.

Analyst Insight

Stockholders should review the proxy statement to understand the proposals and vote their shares before the May 23, 2024 meeting.

Executive Compensation

Key Numbers

• May 23, 2024 — Annual Meeting Date (Date of the annual meeting of stockholders.)
• 10:00 a.m., Eastern Time — Annual Meeting Time (Time of the annual meeting of stockholders.)

Key Players & Entities

• Phathom Pharmaceuticals, Inc. (company) — Registrant
• Terrie Curran (person) — President, Chief Executive Officer and Director
• May 23, 2024 (date) — Annual Meeting date
• 10:00 a.m., Eastern Time (time) — Annual Meeting time
• www.virtualshareholdermeeting.com/PHAT2024 (url) — Virtual meeting platform

FAQ

Industry Context

Phathom Pharmaceuticals operates in the pharmaceutical preparations industry, focusing on developing and commercializing novel treatments.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.

What Investors Should Do

1. Review the proxy statement for details on proposals and voting procedures.
2. Vote shares prior to the May 23, 2024, annual meeting via proxy, internet, or telephone.
3. Attend the virtual annual meeting online to participate and submit questions.

Key Dates

• 2024-05-23: Annual Meeting of Stockholders — Key date for stockholders to vote and participate in company decisions.

Year-Over-Year Comparison

This filing is a DEF 14A proxy statement for the annual meeting, following standard SEC reporting requirements for such events.

Filing Documents

• def_14a-2024_proxy.htm (DEF 14A) — 741KB
• img226992248_0.jpg (GRAPHIC) — 9KB
• img226992248_1.jpg (GRAPHIC) — 633KB
• img226992248_2.jpg (GRAPHIC) — 633KB
• img226992248_3.jpg (GRAPHIC) — 9KB
• img226992248_4.jpg (GRAPHIC) — 363KB
• img226992248_5.jpg (GRAPHIC) — 179KB
• 0000950170-24-044015.txt (&nbsp;) — 3246KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 21

EXECUTIVE COMPENSATION AND OTHER INFORMATION

EXECUTIVE COMPENSATION AND OTHER INFORMATION 25 DELINQUENT SECTION 16(A) REPORTS 33 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 34 STOCKHOLDER PROPOSALS 36 ANNUAL REPORT 37 STOCKHOLDERS SHARING THE SAME ADDRESS 37 OTHER MATTERS 38 iii 100 Campus Drive, Suite 102 Florham Park, NJ 07932 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON THURSDAY, MAY 23, 2024 The board of directors of Phathom Pharmaceuticals, Inc. is soliciting the enclosed proxy for use at the annual meeting of stockholders, including at any adjournments or postponements of the meeting, to be held virtually at www.virtualshareholdermeeting.com/PHAT2024 , on May 23, 2024 at 10:00 a.m., Eastern Time. We have elected to take advantage of Securities and Exchange Commission rules that allow companies to furnish proxy materials to their stockholders by providing access to these documents on the Internet instead of mailing printed copies. Those rules allow a company to provide its stockholders with the information they need, while lowering the costs of delivery and reducing the environmental impact of the annual meeting. Most of our stockholders will not receive printed copies of our proxy materials unless requested, but instead will receive a notice with instructions on how they may access and review our proxy materials on the Internet and how they may cast their vote via the Internet. If you would like to receive a printed or e-mail copy of our proxy materials, please follow the instructions for requesting the materials in the Notice of Internet Availability of Proxy Materials that is being sent to you. We are an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Accordingly, we have elected to comply with the scaled-down executive compensation disclosure requirements applicable to emerging growth companies and we are not required to include a Compensation Discuss

View Full Filing

View this DEF 14A filing on SEC EDGAR